Fundación Pública Andaluza Progreso y Salud

Logo Fundación Publica Andaluza progreso y salud

Contact information

Fundación Pública Andaluza Progreso y Salud
Javier Montero Plata, Director de la Oficina de Transferencia de Tecnología del Sistema Sanitario Público de Andalucía
C/ Isaac Newton 4, 3ª Planta, Noroeste - Pabellón de Italia
Sevilla
Sevilla
955040450
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biodrugs
      • Biomarkers
      • Stem cells
      • Biological defense
      • In vitro diagnostics
      • Medical devices
      • Drug delivery
      • Blood products
      • Screening
      • Cellular Therapy
      • Gene Therapy
      • Biomaterials and tissue therapy
      • Transplant
      • Vaccines
    • Therapeutic areas
      • Analgesia & Pain
      • Dermatology
      • Musculoskeletal system
      • Cardiovascular diseases and circulatory system
      • Genetic and rare diseases
      • Infectious diseases
      • Inflammatory diseases
      • Immunology
      • Odontology
      • Ophtalmology and optometry
      • Oncology
      • Blood and lymphatic system
      • Digestive system and hepatology
      • Kidney and genitourinary system
      • Central nervous system
      • Respiratory and pulmonary system
      • Metabolic disorders / Endocrinology
  • B. Agrifood Biotechnology
    • Food
      • Functional Food
  • C. Industrial Biotechnology
    • Cell lines
  • D. Services
    • R&D services
      • Bioinformatics
      • Biotechnolgy kits
      • Pharmacogenomics
      • Genomics
      • Scientific and technical instruments
      • Internet and information technologies
      • Metabolomics
      • Nanotechnology and in silico biology
      • Proteomics
    • Professional services
      • Training and spreading
      • Human Resources
Commissions

The Andalusian Public Foundation Progress and Health (FPS) is an organization that belongs to the Andalusian Regional Ministry of Health and Social Wellness. It is the central entity which provides services to the Andalusian Public Health System (SSPA) through three areas of activity: support and manage of research, ICT development, and training and professional competence evaluation. 

Products and services

FPS is in duty of technology transfer of the SSPA that is managed by Technology Transfer Office (OTT-SSPA) that is organized as a network structure that collaborates with the Network of Research Management Foundations (RFGI) which operates at a local level.

The OTT-SSPA offers specific services to:

  • SSPA research community:
    • R&D results protection
    • intellectual property rights management
    • technology transfer
    • establishment of business alliances
    • spin-offs creation
  • Healthcare, pharmaceutical and biotechnology industries:
    • research groups identification 
    • technology offers
    • reverse technology transfer
    • public-private financing
    • business attraction

Biotech Sanitaria

Drugs National Companies
Product / Service Type Therapeutic area Development phase
GENYO-20001 CRISPNA, A NEW TOOL FOR GENOME EDITING AND DIAGNOSIS Gene Therapy, Cell Therapy R&D
FISEVI-13002 CANNABIOTICS Biodrugs/ Drugs Oncología Preclinical
FIBICO-14003 LISED OF MESENCHYMAL STEM CELLS FOR THE TREATMENT OF MUSCULAR SKELETAL INJURIES Gene Therapy, Cell Therapy Desórdenes musculoesqueléticos R&D
CABIMER-19002 NON-VIRAL VECTORS FROM MESOPOROUS NANOPARTICLES FOR THEIR APPLICATION IN GENE THERAPY FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA Gene Therapy, Cell Therapy Oftalmología y optometría R&D
CABIMER- 21001 Use of melatonin to improve the therapeutic potential of mesenchymal stem cells in cancer Biodrugs/ Drugs Oncología R&D
Research Platforms
Product / Service Type Development phase
Screening Cell lines & Animal Models Screening/Drug Discovery R&D
Hybridome/Antibody Production Platform Enabling Technologies R&D
Liposome delivery System (Prostate Cancer) Drug Delivery R&D
Maturing technological platform in advanced therapies CRO, CMO Clinical Validation
Diagnostics and Personalised Medicine
Product / Service Type Therapeutic area Development phase
GENYO-21001 MyPROSLE: a new system to measure the personalized molecular dysregulated profiles of Systemic Lupus Erythematosus patients Diagnostic Inmunología R&D
GENYO-19002 METHOD OF OBTAINING USEFUL DATA TO DIAGNOSE HEREDITARY HEMORRHAGIC TELANGIECTASIA Diagnostic Enfermedades cardiovasculares y sistema circulatorio R&D
GENYO-20003 SYSTEM FOR THE SIMULTANEOUS DETECTION OF CHROMOSOME ALTERATIONS THROUGH SEQUENCING, CYTOMETRY AND IMAGE. Diagnostic R&D
FISEVI-20011 FEN-COVID-19 Diagnostic R&D
GENYO-13001 / FIMABIS-13009 Biomarkers Inmunología Preclinical
FISEVI-19002 MedicalForms: Clinical Information Modeling Tool Other R&D
FISEVI-20005 Equivalent dose converter between different drugs Other R&D
FISEVI-15028 Mobile application for the monitoring and diagnosis of surgical wound infections on an outpatient basis using an image-based telemedicine system (Scarcheck) Diagnostic R&D
FISEVI-18026 CellCount-Master Other R&D
FIMABIS-21007 Predict�plus�Prevent Other Abuso de sustancias R&D
FISEVI-15004 Portable vest for the application of pulmonary therapy and associated procedure Other R&D
FIMABIS-20034 Lactoperoxidase as a potential diagnostic method for the presence of Parkinson's disease and response to treatment Diagnostic Sistema nervioso central R&D
FIMABIS-21005 CUIDAVEN Other R&D
FIMABIS-20015 HemoPer: APP for the management of antithrombotics in perioperative, emergency and COVID19 context Other R&D
FIMABIS-20015 HemoPer: APP for the management of antithrombotics in perioperative, emergency and COVID19 context Other R&D
FIBICO-19012 Use of splicing factors as therapeutic targets in prostate cancer. Diagnostic Oncología R&D